期刊文献+

伴复杂核型异常的髓系恶性血液病8号染色体异常分析 被引量:2

Analysis of Chromosome-8 Aberrations in Myeloid Malignancies with Complex Chromosome Abnormalities
下载PDF
导出
摘要 为研究伴复杂核型异常(complex chromosome abnormalities,CCA)的髓系恶性血液病的8号染色体异常,采用常规染色体分析和多重荧光原位杂交技术检测81例伴CCA的髓系恶性血液病患者的染色体异常,其中急性髓系白血病(AML)25例、慢性髓系白血病(CML)35例和骨髓增生异常综合征(MDS)21例。结果表明:81例标本中CCA涉及所有染色体,而8号染色体异常发生率为35.8%(29/81),其中AML为56%(14/25)、CML为28.6%(10/35)、MDS为23.8%(5/21),CML加速期、急变期发生率分别为20%(1/5)、33.3%(9/27)。29例伴8号染色体异常的髓系恶性血液病中有15例为非平衡易位,占51.7%。结论:8号染色体异常是伴CCA的髓系恶性血液病中常见的染色体异常,可能与疾病进展相关,多为不平衡性易位。 To investigate the chromosome-8 aberrations in myeloid malignancies with complex chromosome abnormalities (CCAs), 81 cases of myeloid malignancies with CCAs were analysed by conventional chromosome analysis and multiplex fluorescence in situ hybridization. The 81 cases included 25 cases of acute myeloid leukemia ( AML ), 35 cases of chronic myeloid leukemia (CML) and 21 cases of myelodysplastic syndrome ( MDS ). The results showed that all chromosomes were involved in CCAs, and the incidence of chromosome-8 abnormalitiy was 35.8 % (29 out of 81 cases) in myeloid malignancies with CCAs, which in AML, CML and MDS patients were 56% (14/25), 28.6% ( 10/35 ) and 23.81% ( 5/21 ), respectively. In CML, the incidences of accelerated phase and blast phase were 20% (1/5) and 33.3% (9/27), respectively. The most common aberrations involving chromosome 8 were unbalanced translocations ( 19 out of 29 cases, 51.7% ). In conclusion, aberrations of chromosome 8 were common in myeloid malignancies with CCAs, and may be related to progression of the disease. The most common aberrations were unbalanced translocations.
出处 《中国实验血液学杂志》 CAS CSCD 2008年第5期993-996,共4页 Journal of Experimental Hematology
关键词 髓系恶性血液病 复杂核型异常 8号染色体异常 多重荧光原位杂交 myeloid malignancy complex chromosome aberration chromosome 8 aberration multiplex fluorescence in situ hybridization
  • 相关文献

参考文献15

  • 1Maserati E, Aprili F, Vinante F, et al. Trisomy 8 in myelodys- plasia and acute leukemia is constitutional in 15 - 20% of eases. Genes Chromosomes Cancer, 2002; 33:93 -97
  • 2姜道滋,陈志妹,楼基余,王云贵,梁毅,金洁.1193例慢性粒细胞白血病细胞及分子遗传学分析[J].中华血液学杂志,2007,28(1):1-5. 被引量:19
  • 3Paulsson K, Sail T, Fioretos T, et al. The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology. Cancer Genet Cytogenet, 2001 ; 130:160 -165
  • 4Grimwade D, Walker H, Ofiver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood, 1998; 92:2322-2333
  • 5Johansson B, Fioretos T, Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol, 2002; 107:76-94
  • 6Shaffer LG, Tommerup N. An international system for human cytogenetic nomenclature. Basel: ISCN. 2005 : 1 - 130
  • 7Paulsson K, Fioretos T, Strombeck B, et al. Trisomy 8 as the sole chromosomal aberration in 8 myelocytic malignancies: a multicolor and locus-specific fluorescence in situ hybridization study. Cancer Genet Cytogenet, 2003; 140:66-69
  • 8Virtaneva K, Wright FA, Tanner SM, et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A, 2001; 98:1124-1129
  • 9Blick M, Romero P, Talpaz M, et al. Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genet Cytogenet, 1987 ; 27 : 349 -356
  • 10Jennings BA, Mills KI. Cmyc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukaemia. Leuk Res, 1998; 22:899 -903

二级参考文献11

  • 1薛永权,过宇.Ph染色体阴性和少见Ph易位慢性粒细胞白血病的...[J].中华医学杂志,1993,73(4):209-212. 被引量:5
  • 2Heim S,Billstrom R,Kristoffersson U,et al.Variant Ph translocation in chronic myeloid leukemia.Cancer Genet Cytogenet,1985,18:215-227.
  • 3Hagemeijer A,Bartram CR,Smit EME,et al.Is the chromosomal region 9q34 always involved in variant of the Ph translocation? Cancer Genet Cytogenet,1984,13:1-16.
  • 4Ishihara T,Minamihisamatsu M.The Philadelphia chromosome.Considerations based on studies of variant Ph translocations.Cancer Genet Cytogenet,1988,32:75-92.
  • 5Mitelman F,Johansson B,Mertens F.Database of chromosome aberration in cancer (2001).http://cgap.nci.nih.gov/chromosomes/Mitelman,2001.
  • 6Cortes JE,Talpaz M,Giles F,et al.Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy.Blood,2003,101:3794-3800.
  • 7Hashimoto T,Ohtki M,Kamada N,et al.Application of log-linear model in inference on karyotypic evolution in chronic myelocytic leukemia.Environ Health Perspect,1990,87:135-141.
  • 8Ineue T,Tnjo A,Tsuchimono D,et al.Possible correlation between fusion pattern of bcr-abl mRNA and clinical response to alpha interferon in chronic myelogenous leukemia.Leukemia,1992,9:948-951.
  • 9谢新,过宇,薛永权.600例慢性粒细胞白血病的细胞遗传学分析[J].中华医学遗传学杂志,1998,15(2):85-88. 被引量:14
  • 10陈志妹,金洁,楼基余,林茂芳.慢性粒细胞白血病353例的染色体核型分析[J].中华内科杂志,2002,41(6):414-414. 被引量:4

共引文献18

同被引文献38

  • 1李建勇,马力,肖冰,潘金兰,仇海荣,吴亚芳,温丙昭,薛永权.多色荧光原位杂交技术检测急性淋巴细胞白血病复杂核型异常[J].中国实验血液学杂志,2006,14(1):42-45. 被引量:5
  • 2马力,李建勇,潘金兰,肖冰,钱思轩,陈丽娟,仇海荣,温丙昭,薛永权.多重荧光原位杂交技术检测急性髓系白血病复杂核型异常的价值[J].中华血液学杂志,2006,27(5):318-322. 被引量:5
  • 3王小钦,林果为.282例原发性骨髓增生异常综合征诊断和分型的前瞻性临床研究[J].中华血液学杂志,2006,27(8):546-549. 被引量:34
  • 4陈丽娟,李建勇,潘金兰,薛永权.分子细胞遗传学技术在血液病中的应用[J].实用临床医药杂志,2006,10(5):28-33. 被引量:2
  • 5Haferlach T, Bacher U, Kern W, et al. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach. Ann Hematol,2007 ;86 ( 5 ) :311 - 327.
  • 6Azofeifa J, Fauth C, Kraus J, et al. An optimized probe set for the detection of small interchrornosomal aberrations by use of 24-color FISH. Am J Hum Genet,2000; 66(5) :1684 - 1688.
  • 7Suela J, Alvarez S, Cifuentes F, et al. DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups. Leukemia,2007 ;21 (6) :1224 - 1231.
  • 8Byrd JC, Mro'zek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461 ). Blood, 2002;100(13) :4325 -4336.
  • 9El-Rifai W, Ruutu T, Elonen E, et al. Prognostic value of metaphase-fluorescence in situ hybridization in follow-up of patients with acute myeloid leukemia in remission . Blood, 1997;89 (9) :3330 -3334.
  • 10Brizard K, Cividin M, Villalvae C, et al. Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CIVIL. Leuk Res, 2004;28(4) :345 -348.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部